Rows of fruits and vegetables of many varieties lined the vendor stalls at the Scranton Co-Op Farmers Market as people shopped on the market’s opening day Friday afternoon. But missing from the stands ...

Summit Therapeutics has revealed that a second pivotal trial of its Akeso-partnered PD-1xVEGF bispecific ivonescimab has failed to show an improvement in overall survival in a lung cancer trial.